Lüttgen Maria, Elvander Elin, Madjid Nather, Ogren Sven Ove
Division of Behavioral Neuroscience, Department of Neuroscience, B3:5, Retzius väg 8, Karolinska Institutet, S-171 77 Stockholm, Sweden.
Neuropharmacology. 2005 May;48(6):830-52. doi: 10.1016/j.neuropharm.2005.01.007.
The role of the brain 5-HT1A receptor in cognition was examined in the water maze (WM) and passive avoidance (PA) tasks in the male rat. Pre-training administration of the 5-HT1A receptor agonist 8-OH-DPAT impaired WM performance and facilitated PA retention at low doses (0.01 and 0.03 mg/kg) and impaired PA retention at higher doses (0.1-1.0 mg/kg). The 5-HT1A receptor antagonist NAD-299 produced a dose-dependent facilitation of PA retention. In contrast, the 5-HT1A receptor antagonists NAD-299 and WAY-100635 failed to alter acquisition and retention in the WM. The impairments in WM and PA (but not facilitation in PA) induced by 8-OH-DPAT were blocked by NAD-299. Furthermore, NAD-299 prevented the PA impairments induced by the muscarinic antagonist scopolamine or the NMDA receptor antagonist MK-801. In contrast, NAD-299 and WAY-100635 failed to attenuate the WM impairment induced by scopolamine, probably due to the failure of 5-HT1A receptor blockade to attenuate the sensorimotor disturbances induced by scopolamine. These results indicate that 5-HT1A receptor stimulation and blockade result in opposite effects in two types of cognitive tasks in the rat, and that 5-HT1A receptor blockade can facilitate some aspects of cognitive function, probably via modulation of cholinergic and glutamatergic transmissions. This suggests that 5-HT1A receptor antagonists may have a potential role in the treatment of human degenerative disorders associated with cognitive deficits.
在雄性大鼠的水迷宫(WM)和被动回避(PA)任务中研究了大脑5-羟色胺1A(5-HT1A)受体在认知中的作用。5-HT1A受体激动剂8-羟基二丙胺四乙酸(8-OH-DPAT)在预训练给药时,低剂量(0.01和0.03mg/kg)会损害WM表现并促进PA记忆保持,而高剂量(0.1 - 1.0mg/kg)则会损害PA记忆保持。5-HT1A受体拮抗剂NAD - 299产生了剂量依赖性的PA记忆保持促进作用。相比之下,5-HT1A受体拮抗剂NAD - 299和N-(2-(4-甲氧基苯基)乙基)-N-(2-吡啶基)环己烷甲酰胺(WAY - 100635)未能改变WM中的习得和记忆保持。NAD - 299阻断了8-OH-DPAT诱导的WM和PA损害(但不是PA促进作用)。此外,NAD - 299预防了毒蕈碱拮抗剂东莨菪碱或N-甲基-D-天冬氨酸(NMDA)受体拮抗剂MK - 801诱导的PA损害。相比之下,NAD - 299和WAY - 100635未能减轻东莨菪碱诱导的WM损害,这可能是由于5-HT1A受体阻断未能减轻东莨菪碱诱导的感觉运动障碍。这些结果表明,5-HT1A受体刺激和阻断在大鼠的两种认知任务中产生相反的效果,并且5-HT1A受体阻断可能通过调节胆碱能和谷氨酸能传递促进认知功能的某些方面。这表明5-HT1A受体拮抗剂可能在治疗与认知缺陷相关的人类退行性疾病中具有潜在作用。